| 000 | 01598 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250512123019.0 | ||
| 264 | 0 | _c19731011 | |
| 008 | 197310s 0 0 eng d | ||
| 022 | _a0024-4201 | ||
| 024 | 7 |
_a10.1007/BF02531712 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aNewman, H A | |
| 245 | 0 | 0 |
_aDifferential effects of benzodioxane, chroman and dihydrobenzofuran analogs of clofibrate in a Triton hyperlipemic rat model. _h[electronic resource] |
| 260 |
_bLipids _cJul 1973 |
||
| 300 |
_a378-84 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAnticholesteremic Agents _xpharmacology |
| 650 | 0 | 4 |
_aBenzene Derivatives _xpharmacology |
| 650 | 0 | 4 |
_aBenzofurans _xpharmacology |
| 650 | 0 | 4 |
_aBenzopyrans _xpharmacology |
| 650 | 0 | 4 |
_aCarboxylic Acids _xpharmacology |
| 650 | 0 | 4 |
_aCholesterol _xblood |
| 650 | 0 | 4 |
_aClofibrate _xpharmacology |
| 650 | 0 | 4 | _aDensitometry |
| 650 | 0 | 4 |
_aDioxins _xpharmacology |
| 650 | 0 | 4 | _aDisease Models, Animal |
| 650 | 0 | 4 | _aElectrophoresis |
| 650 | 0 | 4 |
_aEsters _xpharmacology |
| 650 | 0 | 4 |
_aHyperlipidemias _xblood |
| 650 | 0 | 4 |
_aHypolipidemic Agents _xpharmacology |
| 650 | 0 | 4 |
_aLipids _xblood |
| 650 | 0 | 4 |
_aLipoproteins _xblood |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aStructure-Activity Relationship |
| 650 | 0 | 4 | _aSurface-Active Agents |
| 650 | 0 | 4 |
_aTriglycerides _xblood |
| 700 | 1 | _aHeilman, W P | |
| 700 | 1 | _aWitiak, D T | |
| 773 | 0 |
_tLipids _gvol. 8 _gno. 7 _gp. 378-84 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/BF02531712 _zAvailable from publisher's website |
| 999 |
_c4727635 _d4727635 |
||